Literature DB >> 15004046

Comparison of PCR with the routine procedure for diagnosis of tuberculosis in a population with high prevalences of tuberculosis and human immunodeficiency virus.

Lydia Kivihya-Ndugga1, Maarten van Cleeff, Ernest Juma, Joseph Kimwomi, Willie Githui, Linda Oskam, Anja Schuitema, Dick van Soolingen, Lucy Nganga, Daniel Kibuga, Joseph Odhiambo, Paul Klatser.   

Abstract

Direct smear examination with Ziehl-Neelsen (ZN) staining for the diagnosis of tuberculosis (TB) as employed in most low-income countries is cheap and easy to use, but its low sensitivity is a major drawback. The low specificity of chest X-rays, used for the diagnosis of smear-negative TB, risks high levels of overdiagnosis. Major advances in molecular techniques, which rapidly identify mycobacterial DNA in sputa, may overcome these obstacles. In this study, the AMPLICOR PCR system was used to diagnose pulmonary TB in a developing country with high prevalences of both TB and human immunodeficiency virus (HIV). The sensitivity and specificity of this technique were compared to those of the usual diagnostic techniques. Sputum specimens were collected from 1,396 TB suspects attending the Rhodes Chest Clinic, Nairobi, Kenya. The specimens were analyzed for the presence of Mycobacterium tuberculosis by PCR; culture on Löwenstein-Jensen medium was used as the "gold standard." All culture-positive samples were genotyped to identify the mycobacterial species. The sensitivity and specificity of PCR were 93 and 84%, respectively. HIV status did not affect the sensitivity of PCR. A total of 99.7% of the true smear-positive and 82.1% of the true smear-negative TB patients were correctly identified by PCR. PCR detected M. tuberculosis in 11.7% of the culture-negative suspects, 60% of which had one or two PCR-positive sputum specimens. Of the 490 positive cultures, 486 were identified as M. tuberculosis. The high sensitivity of Amplicor PCR merits usage in a clinical setting with high TB and HIV burdens. Thus, PCR can be considered as an alternative to ZN staining in combination with chest X-ray for diagnosis of TB; however, cost-effectiveness studies and operational studies are required to support an evidence-based decision of introducing PCR for TB control in high-burden environments.

Entities:  

Mesh:

Year:  2004        PMID: 15004046      PMCID: PMC356878          DOI: 10.1128/JCM.42.3.1012-1015.2004

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  9 in total

Review 1.  New diagnostic tools for tuberculosis.

Authors:  M D Perkins
Journal:  Int J Tuberc Lung Dis       Date:  2000-12       Impact factor: 2.373

2.  A comprehensive study of the efficiency of the routine pulmonary tuberculosis diagnostic process in Nairobi.

Authors:  M R A van Cleeff; L Kivihya-Ndugga; W Githui; L Nganga; J Odhiambo; P R Klatser
Journal:  Int J Tuberc Lung Dis       Date:  2003-02       Impact factor: 2.373

3.  Top ten biotechnologies for improving health in developing countries.

Authors:  Abdallah S Daar; Halla Thorsteinsdóttir; Douglas K Martin; Alyna C Smith; Shauna Nast; Peter A Singer
Journal:  Nat Genet       Date:  2002-10       Impact factor: 38.330

Review 4.  Molecular diagnosis of mycobacteria.

Authors:  H Soini; J M Musser
Journal:  Clin Chem       Date:  2001-05       Impact factor: 8.327

Review 5.  Molecular techniques in mycobacterial detection.

Authors:  G L Woods
Journal:  Arch Pathol Lab Med       Date:  2001-01       Impact factor: 5.534

6.  Molecular detection of Mycobacterium tuberculosis: impact on patient care.

Authors:  K L Kaul
Journal:  Clin Chem       Date:  2001-08       Impact factor: 8.327

7.  Utility of nucleic acid amplification techniques for the diagnosis of pulmonary tuberculosis in sub-Saharan Africa.

Authors:  B Kambashi; G Mbulo; R McNerney; R Tembwe; A Kambashi; V Tihon; P Godfrey-Faussett
Journal:  Int J Tuberc Lung Dis       Date:  2001-04       Impact factor: 2.373

8.  Cost-effectiveness of the polymerase chain reaction versus smear examination for the diagnosis of tuberculosis in Kenya: a theoretical model.

Authors:  B R Roos; M R van Cleeff; W A Githui; L Kivihya-Ndugga; J A Odhiambo; D K Kibuga; P R Klatser
Journal:  Int J Tuberc Lung Dis       Date:  1998-03       Impact factor: 2.373

9.  Assessment by meta-analysis of PCR for diagnosis of smear-negative pulmonary tuberculosis.

Authors:  Olga L Sarmiento; Kristen A Weigle; Janet Alexander; David J Weber; William C Miller
Journal:  J Clin Microbiol       Date:  2003-07       Impact factor: 5.948

  9 in total
  32 in total

1.  Rapid detection of Mycobacterium tuberculosis in clinical samples by multiplex polymerase chain reaction (mPCR).

Authors:  Thean-Hock Tang; Siti Aminah Ahmed; Mustaffa Musa; Zainul Fadziruddin Zainuddin
Journal:  World J Microbiol Biotechnol       Date:  2013-06-27       Impact factor: 3.312

Review 2.  Improving the diagnosis of tuberculosis: From QuantiFERON to new techniques to diagnose tuberculosis infections.

Authors:  Amy Y Vittor; Joseph M Garland; David Schlossberg
Journal:  Curr HIV/AIDS Rep       Date:  2011-09       Impact factor: 5.071

3.  Intensive tuberculosis screening for HIV-infected patients starting antiretroviral therapy in Durban, South Africa.

Authors:  Ingrid V Bassett; Bingxia Wang; Senica Chetty; Janet Giddy; Elena Losina; Matilda Mazibuko; Benjamin Bearnot; Jenny Allen; Rochelle P Walensky; Kenneth A Freedberg
Journal:  Clin Infect Dis       Date:  2010-10-01       Impact factor: 9.079

Review 4.  Novel developments in the epidemic of human immunodeficiency virus and tuberculosis coinfection.

Authors:  Asha Anandaiah; Keertan Dheda; Joseph Keane; Henry Koziel; David A J Moore; Naimish R Patel
Journal:  Am J Respir Crit Care Med       Date:  2010-12-22       Impact factor: 21.405

5.  Multidetector CT findings of histopathologically proven peritoneal tuberculous cold abscesses.

Authors:  Jae-Joon Chung; Jeong Min Choi; Eun-Suk Cho; Joo Hee Kim; Jeong-Sik Yu
Journal:  Radiol Med       Date:  2017-01-21       Impact factor: 3.469

6.  The relevance of biopsy in tuberculosis patients without human immunodeficiency virus infection.

Authors:  Kyung Min Bae; Sung-Chul Lim; Hyung Ho Kim; Woo Jin Lee; Na Ra Yun; Choon-Mee Kim; Dong-Min Kim
Journal:  Am J Trop Med Hyg       Date:  2014-12-08       Impact factor: 2.345

7.  Cost-effectiveness analysis of PCR for the rapid diagnosis of pulmonary tuberculosis.

Authors:  Luciene C Scherer; Rosa D Sperhacke; Antonio Ruffino-Netto; Maria Lr Rossetti; Claudia Vater; Paul Klatser; Afrânio L Kritski
Journal:  BMC Infect Dis       Date:  2009-12-31       Impact factor: 3.090

8.  Rapid detection of Mycobacterium tuberculosis and pyrazinamide susceptibility related to pncA mutations in sputum specimens through an integrated gene-to-protein function approach.

Authors:  Heng Li; Jun Chen; Man Zhou; Xuelei Geng; Junping Yu; Weihua Wang; Xian-En Zhang; Hongping Wei
Journal:  J Clin Microbiol       Date:  2013-11-13       Impact factor: 5.948

9.  Comparison of two laboratory-developed PCR methods for the diagnosis of pulmonary tuberculosis in Brazilian patients with and without HIV infection.

Authors:  Luciene C Scherer; Rosa D Sperhacke; Carla Jarczewski; Patrícia I Cafrune; Candice T Michelon; Rubia Rupenthal; Marta Osorio Ribeiro; Antonio Ruffino Netto; Maria L R Rossetti; Afrânio L Kritski
Journal:  BMC Pulm Med       Date:  2011-03-29       Impact factor: 3.317

10.  Nucleic acid amplification tests for diagnosis of smear-negative TB in a high HIV-prevalence setting: a prospective cohort study.

Authors:  J Lucian Davis; Laurence Huang; William Worodria; Henry Masur; Adithya Cattamanchi; Charles Huber; Cecily Miller; Patricia S Conville; Patrick Murray; Joseph A Kovacs
Journal:  PLoS One       Date:  2011-01-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.